{
    "eid": "2-s2.0-85047131862",
    "title": "Episodic memory and delayed recall are significantly more impaired in younger patients with deficit schizophrenia than in elderly patients with amnestic mild cognitive impairment",
    "cover-date": "2018-05-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Biochemistry, Genetics and Molecular Biology (all)",
            "@code": "1300",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Agricultural and Biological Sciences (all)",
            "@code": "1100",
            "@abbrev": "AGRI"
        },
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Buranee Kanchanatawan",
        "Sookjaroen Tangwongchai",
        "Thitiporn Supasitthumrong",
        "Sira Sriswasdi",
        "Michael Maes"
    ],
    "citedby-count": 7,
    "ref-count": 54,
    "ref-list": [
        "Mild cognitive impairment: Clinical characterization and outcome",
        "Mild cognitive impairment: An overview",
        "Does vascular MCI progress at a different rate than does amnestic MCI?",
        "The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment",
        "The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease",
        "Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials",
        "Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment",
        "CERAD (Consortium to Establish a Registry for Alzheimer\u2019s Disease) The first 20 years",
        "Pre-MCI and MCI: Neuropsychological, clinical, and imaging features and progression rates",
        "Mild cognitive impairment and Alzheimer\u2019s disease: An investigation of the CERAD-NP test battery",
        "A total score for the CERAD neuropsychological battery",
        "CERAD test performances in amnestic mild cognitive impairment and Alzheimer\u2019s disease",
        "CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: The AddNeuroMed study",
        "Total scores of the CERAD neuropsychological assessment battery: Validation for mild cognitive impairment and dementia patients with diverse etiologies",
        "Spoken Language Derived Measures for Detecting Mild Cognitive Impairment",
        "Deficit schizophrenia: An update",
        "Changes in Tryptophan Catabolite (TRYCAT) pathway patterning are associated with mild impairments in declarative memory in schizophrenia and deficits in semantic and episodic memory coupled with increased false-memory creation in deficit schizophrenia",
        "Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: Results of supervised machine learning",
        "Mild cognitive impairment as a diagnostic entity",
        "The Schedule for the Deficit syndrome: An instrument for research in schizophrenia",
        "The Clinical Dementia Rating (CDR): Current version and scoring rules",
        "Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician",
        "Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing",
        "Cognition in schizophrenia: Core psychological and neural mechanisms",
        "A Meta-Analysis of Autobiographical Memory Studies in Schizophrenia Spectrum Disorder",
        "Episodic memory and impairment of an early encoding process in schizophrenia",
        "CE verbal episodic memory impairment in schizophrenia: A comparison with frontal lobe lesion patients",
        "Cognitive functioning in late-life schizophrenia: A comparison of elderly schizophrenic patients and patients with Alzheimer\u2019s disease",
        "Neurocognitive impairment in deficit and non-deficit schizophrenia: A meta-analysis",
        "Language performance in Alzheimer\u2019s disease and mild cognitive impairment: A comparative review",
        "Could language deficits really differentiate Mild Cognitive Impairment (MCI) from mild Alzheimer\u2019s disease?",
        "Multiple category verbal fluency in mild cognitive impairment and correlation with CSF biomarkers for Alzheimer\u2019s disease",
        "Predicting the severity of everyday functional disability in people with schizophrenia: Cognitive deficits, functional capacity, symptoms, and health status",
        "Affective reactivity of speech and emotional experience in patients with schizophrenia",
        "Physical performance and disability in schizophrenia",
        "Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries",
        "Beta-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review",
        "Association of Cerebral Amyloid-beta Aggregation With Cognitive Functioning in Persons Without Dementia",
        "Underlying Biological Processes in Mild Cognitive Impairment: Amyloidosis Versus Neurodegeneration",
        "Specificity deficit in the recollection of emotional memories in schizophrenia",
        "Limits and uncertainties about the concept of MCI: Contribution of neuropsychological approach",
        "Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: A report from the Einstein Aging Study",
        "Clinical, pathological, and neuro-chemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques",
        "Cognitive and social lifestyle: Links with neuropathology and cognition in late life",
        "Lifetime antecedents of cognitive reserve",
        "The MATRICS consensus cognitive battery, part 1: Test selection, reliability, and validity",
        "Current concepts in mild cognitive impairment",
        "Advantages and disadvantages of using artificial neural networks versus logistic regression for predicting medical outcomes"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        }
    ],
    "funding": []
}